YCBD (cbdMD Inc.) Market Value to Book Value Ratio

Official company branding of cbdmd.com (YCBD)

The implementation of AI logistics and packaging automation optimizes e-commerce flows, which is reflected in the market capitalization to book value ratio. This metric currently stands at 0.49. The fundamentals rely on robotic oil dosing for mass production and strategic partnerships with wellness brands, which stimulate retail sales for cbdMD, Inc. (YCBD).

YCBD cbdmd.com: Market Value to Book Value in the range 07/04/2022 - 10/28/2026

Financial and market metric breakdowns for cbdMD, Inc. (YCBD)

- price and consensus price forecast:
Stock Price cbdmd.com|YCBD - Broker Consensus Forecast
- market capitalization data:
Market Value cbdMD Corp|YCBD - Full Business Value
- book capitalization data:
Book Value per Share cbdMD|YCBD - Accounting Value of Company|Market Capitalization to Book Value Ratio cbdmd.com|YCBD - Company Total Assets
- debt and liquidity data:
Debt to Equity cbdMD, Inc.|YCBD - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity cbdmd.com|YCBD - Company Total Debt|Debts to Book Capitalization cbdMD Corp
Initial company analysis:cbdMD Inc. - YCBD
Original product of cbdmd.com

The ratio is calculated by dividing the company's market capitalization by the value of its net assets. This metric determines the premium or discount of the market valuation relative to actual equity, accounting for debt obligations. For cbdMD, Inc. (YCBD), this reflects market confidence in the effectiveness of the brand restructuring. By analyzing the market-to-book value chart, an investor can assess the level of trust in management under budget constraints.

Main competitors

Market Capitalization to Book Value Ratio Haleon plc|KVUE (kenvue.com) - Capitalization to Book Value Ratio|Market Value to Book Value Ratio Verona Pharma VRNA|Market Capitalization to Net Assets Jyong Biotech Limited|Ligand Pharma (LGND) - Market Capitalization to Book Value Ratio|Market Value to Book Value Amneal Corp (AMRX)|Market Capitalization to Book Value Ratio PRGO (Perrigo Company plc)|alvotech.com - Market Capitalization to Book Value Ratio|Market Value to Book Value Ratio Liquidia (LQDA)|GLPG: Market Value to Book Value|ANIP (ANI Pharma) - Market Value to Book Value Ratio|Afrezza (MNKD) - Market Cap to Net Assets Ratio|AMPH (Amphastar Pharmaceuticals) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio pacira.com (PCRX)|ARS Pharmaceuticals, Inc. (SPRY) - Market Cap to Net Assets Ratio|Market Value to Book Value TBPH (Theravance Biopharma Inc)|AQST: Market Value to Book Value Ratio|SCPH - Market-to-Book Ratio|Market Cap to Net Assets Ratio Tectonic TECX|TNXP - Market Cap to Book Value Multiple|Market Capitalization to Book Value Ratio sxtchina.com SXTC|Eupraxia Pharmaceuticals Inc. (EPRX) - Market Value to Book Value|Market Capitalization to Book Value Ratio BHST (BioHarvest)|Market-to-Book Ratio EXOZ|Oramed Pharmaceuticals (ORMP) - Market Value to Book Value Ratio|Market Value to Book Value enterabio.com (ENTX)|MindWalk Holdings Inc. - Market Capitalization to Book Value Ratio|Market Cap to Net Assets Ratio ABVC BioPharma Inc. ABVC|CPIX - Market Capitalization to Book Value Ratio|QNTM - Market Value to Book Value Ratio|Market Capitalization to Book Value Ratio FibroGen, Inc.|TELO (telomirpharma.com) - Capitalization to Book Value Ratio|Market Value to Book Value Ratio RANI|Market Cap to Net Assets Ratio Synergy CHC Corporation|Market Capitalization to Book Value Ratio Rallybio Corporation RLYB|Capitalization to Book Value Ratio lexariabioscience.com LEXX|Market Cap to Net Assets Ratio Pulmatrix, Inc.|Market Value to Book Value Pheton Holdings Limited PTHL|Market Capitalization to Book Value Ratio APM (Aptorum)|LYRA: Market Capitalization to Book Value|Market Value to Book Value Ratio Impact BioMedical|TNF Pharmaceuticals, Inc. (TNFA) - Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio PRFX|Market Cap to Net Assets Ratio Auris Medical (CYTO)|LIPO (Lipella Pharmaceuticals, Inc.) - Market Cap to Net Assets Ratio|Market Capitalization to Book Value OptiNose Inc OPTN|PIRS: Market Cap to Net Assets Ratio|Market-to-Book Ratio Procaps Group Corp PROC|PTPI: Market Capitalization to Book Value Ratio|QLI - Market Cap to Net Assets Ratio|ACELYRIN (SLRN) - Market Capitalization to Book Value Ratio|TFF Pharmaceuticals Inc. (TFFP) - Market Value to Book Value Ratio